Tesla shares rise on strong 2nd-quarter profits, but the company still needs cash. Bill Mann analyzes Tesla’s short-term future and why Elon Musk continues to set ambitious production targets. Teva Pharmaceuticals sinks to a 13-year low on a bad 2nd-quarter report combined with slashing the dividend. Plus, Bill shares observations, both business and personal, from his recent trip to Africa.
Thanks to Bombfell for supporting The Motley Fool. Get $25 off your first purchase at http://bombfell.com/fool
📆 2017-08-02 20:27 / ⌛ 00:34:21
📆 2017-08-01 18:59 / ⌛ 00:15:02
📆 2017-07-31 18:18 / ⌛ 00:21:25
📆 2017-07-27 20:30 / ⌛ 00:20:43
📆 2017-07-26 20:57 / ⌛ 00:30:09